Haywood analyst Neal Gilmer reiterated a Buy rating on Verano Holdings today and set a price target of C$3.75.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Neal Gilmer has given his Buy rating due to a combination of factors including solid quarterly execution and improving profitability. Verano’s Q4/25 revenue and adjusted EBITDA closely matched both his forecasts and market expectations, while gross margins rebounded meaningfully from the prior quarter, supporting a healthier earnings profile and cash generation.
Gilmer also views the company’s balance sheet and growth initiatives favorably. The recent refinancing into a new term loan with a longer maturity and flexible prepayment terms improves financial visibility, while disciplined retail expansion in key states and a new conditional license in Texas position Verano for continued top-line growth and operational leverage.
Gilmer covers the Healthcare sector, focusing on stocks such as Organigram Global, Green Thumb Industries, and Trulieve Cannabis. According to TipRanks, Gilmer has an average return of -2.0% and a 41.18% success rate on recommended stocks.